CGB8
Basic information
Region (hg38): 19:49047638-49049111
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CGB8 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 21 | 24 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 21 | 3 | 0 |
Variants in CGB8
This is a list of pathogenic ClinVar variants found in the CGB8 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-49047671-G-C | not specified | Uncertain significance (Apr 01, 2024) | ||
19-49047703-A-T | not specified | Uncertain significance (Jan 23, 2024) | ||
19-49047740-G-A | not specified | Uncertain significance (May 30, 2023) | ||
19-49047752-C-G | not specified | Uncertain significance (Dec 18, 2023) | ||
19-49047752-C-T | not specified | Likely benign (Oct 14, 2023) | ||
19-49047773-G-T | not specified | Uncertain significance (Apr 16, 2024) | ||
19-49047779-T-A | not specified | Uncertain significance (Oct 10, 2023) | ||
19-49047797-T-G | not specified | Uncertain significance (Nov 03, 2023) | ||
19-49047828-G-C | not specified | Uncertain significance (Jun 17, 2024) | ||
19-49047867-C-A | not specified | Uncertain significance (Jan 16, 2024) | ||
19-49047872-C-T | not specified | Uncertain significance (Mar 07, 2024) | ||
19-49047875-G-A | not specified | Uncertain significance (Jan 10, 2022) | ||
19-49047914-C-T | not specified | Uncertain significance (Mar 04, 2024) | ||
19-49047920-T-G | not specified | Likely benign (May 25, 2022) | ||
19-49047930-C-T | not specified | Uncertain significance (Sep 27, 2021) | ||
19-49047944-G-C | not specified | Uncertain significance (May 15, 2024) | ||
19-49047953-C-G | not specified | Likely benign (Aug 02, 2021) | ||
19-49047963-C-T | not specified | Uncertain significance (Dec 26, 2023) | ||
19-49048207-T-C | not specified | Uncertain significance (Feb 03, 2022) | ||
19-49048243-C-G | not specified | Uncertain significance (Jun 05, 2024) | ||
19-49048305-C-T | not specified | Uncertain significance (Jan 07, 2022) | ||
19-49048311-C-T | not specified | Uncertain significance (Feb 15, 2023) | ||
19-49048317-G-A | not specified | Uncertain significance (Jan 03, 2024) | ||
19-49048339-C-T | not specified | Uncertain significance (Mar 21, 2024) | ||
19-49048347-C-T | not specified | Uncertain significance (Mar 29, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CGB8 | protein_coding | protein_coding | ENST00000448456 | 3 | 1506 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0160 | 0.482 | 125565 | 0 | 3 | 125568 | 0.0000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -2.07 | 40 | 16.4 | 2.44 | 0.00000105 | 1003 |
Missense in Polyphen | 17 | 5.5305 | 3.0739 | 480 | ||
Synonymous | -2.51 | 14 | 6.11 | 2.29 | 2.99e-7 | 359 |
Loss of Function | -0.613 | 2 | 1.26 | 1.59 | 5.38e-8 | 35 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000264 | 0.0000264 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Beta subunit of the human chorionic gonadotropin (hCG). hCG is a complex glycoprotein composed of two glycosylated subunits alpha and beta which are non-covalently associated. The alpha subunit is identical to those in the pituitary gonadotropin hormones (LH, FSH and TSH). The beta subunits are distinct in each of the hormones and confer receptor and biological specificity. Has an essential role in pregnancy and maternal adaptation. Stimulates the ovaries to synthesize the steroids that are essential for the maintenance of pregnancy. {ECO:0000305}.;
- Pathway
- Gene expression (Transcription);Peptide hormone metabolism;Generic Transcription Pathway;Metabolism of proteins;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;RNA Polymerase II Transcription;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;GPCR signaling-G alpha i;Glycoprotein hormones;Peptide hormone biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.0808
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.394
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Low | Low | Low |
Primary Immunodeficiency | Medium | Low | Medium |
Cancer | Low | Low | Low |